ANTIBODY-MEDIATED REJECTION OF KIDNEY GRAFTS: COMPARISON OF STANDARD THERAPY AND THERAPY WITH ADDITION OF BORTEZOMIB AND/ OR RITUXIMAB

被引：0

作者：

Oblak, Teja ^{[1
]}

Lindic, Jelka ^{[1
]}

Kveder, Radoslav ^{[1
]}

Rigler, Andreja Ales ^{[1
]}

Skoberne, Andrej ^{[1
]}

Haler, Zeljka Veceric ^{[1
]}

Borstnar, Spela ^{[1
]}

Avgustin, Nusa ^{[1
]}

Gubensek, Jakob ^{[1
]}

Ponikvar, Rafael ^{[1
]}

Mlinsek, Gregor ^{[1
]}

Ferluga, Dusan ^{[2
]}

Kojc, Nika ^{[2
]}

Kovac, Damjan ^{[1
]}

机构：

[1] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia

[2] Univ Ljubljana, Inst Pathol, Med Fac, Ljubljana, Slovenia

来源：

TRANSPLANT INTERNATIONAL | 2017年 / 30卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

MP059

引用

页码：386 / 386

页数：1

共 50 条

[21] Adjunctive Bortezomib Therapy for Treatment of Antibody Mediated Rejection in Kidney Transplant Recipients.
McDermott, J.
Lee, J.
Aull, M.
Muthukumar, T.
Hartono, C.
Serur, D.
Lee, J.
Sharma, V.
Kim, J.
Watkins, A.
Kapur, S.
Suthanthiran, M.
Dadhania, D.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 328 - 328
[22] USE OF BORTEZOMIB AS RESCUE THERAPY FOR ANTIBODY MEDIATED REJECTION IN PEDIATRIC KIDNEY TRANSPLANT RECIPIENTS
Brennan, J.
Brakeman, P.
Gonzalez, L.
PEDIATRIC TRANSPLANTATION, 2015, 19 : 86 - 86
[23] Preconditioning Therapy To Prevent Antibody-Mediated Rejection.
Byrne, G. W.
Stalboerger, P. G.
McGregor, C. G. A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 277 - 278
[24] Current and future challenges in therapy for antibody-mediated rejection
Nair, Nandini
Ball, Timothy
Uber, Patricia A.
Mehra, Mandeep R.
JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (06): : 612 - 617
[25] Pneumocystis jirovecii pneumonia after rituximab therapy for antibody-mediated rejection in a renal transplant recipient
Kumar, D.
Gourishankar, S.
Mueller, T.
Cockfield, S.
Weinkauf, J.
Vethanayagam, D.
Humar, A.
TRANSPLANT INFECTIOUS DISEASE, 2009, 11 (02) : 167 - 170
[26] Progressive Multifocal Leukoencephalopathy in a Heart Transplant Recipient Following Rituximab Therapy for Antibody-Mediated Rejection
Loyaga-Rendon, R. Y.
Taylor, D. O.
Koval, C. E.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (04) : 1075 - 1079
[27] Daratumumab for Antibody-mediated Rejection in Heart Transplant-A Novel Therapy: Successful Treatment of Antibody-mediated Rejection
Aguilera Agudo, Cristina
Gomez Bueno, Manuel
Krsnik Castello, Isabel
TRANSPLANTATION, 2021, 105 (03) : E30 - E31
[28] Comparison of Clinical Characteristics and Outcomes of Early Antibody-Mediated Rejection and Late Antibody-Mediated Rejection after Kidney Transplantation
Chen, G.
Wu, Z.
Wang, C.
Liu, X.
Li, Q.
Chen, L.
AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 846 - 846
[29] Bortezomib for antibody-mediated rejection of kidney transplant in youth: Associations with donor-specific antibody
Fulchiero, Rosanna
Galea, Lauren
Hewlett, Jennifer
Savant, Jonathan D.
Lopez, Sonya
Amaral, Sandra
Viteri, Bernarda
PEDIATRIC TRANSPLANTATION, 2024, 28 (05)
[30] Rituximab and Intravenous Immunoglobulin Treatment of Chronic Antibody-Mediated Kidney Allograft Rejection
Fehr, Thomas
Ruesi, Barbara
Fischer, Andreas
Hopfer, Helmut
Wuethrich, Rudolf P.
Gaspert, Ariana
TRANSPLANTATION, 2009, 87 (12) : 1837 - 1841

← 1 2 3 4 5 →